Diagnosis of Sleep Apnoea Using a Mandibular Monitor and Machine Learning Analysis: One-Night Agreement Compared to in-Home Polysomnography.

automated machine learning analysis in-home diagnosis mandibular monitor one-night agreement performance polysomnography sleep apnoea

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2022
Historique:
received: 17 06 2021
accepted: 22 02 2022
entrez: 4 4 2022
pubmed: 5 4 2022
medline: 5 4 2022
Statut: epublish

Résumé

The capacity to diagnose obstructive sleep apnoea (OSA) must be expanded to meet an estimated disease burden of nearly one billion people worldwide. Validated alternatives to the gold standard polysomnography (PSG) will improve access to testing and treatment. This study aimed to evaluate the diagnosis of OSA, using measurements of mandibular movement (MM) combined with automated machine learning analysis, compared to in-home PSG. 40 suspected OSA patients underwent single overnight in-home sleep testing with PSG (Nox A1, ResMed, Australia) and simultaneous MM monitoring (Sunrise, Sunrise SA, Belgium). PSG recordings were manually analysed by two expert sleep centres (Grenoble and London); MM analysis was automated. The Obstructive Respiratory Disturbance Index calculated from the MM monitoring (MM-ORDI) was compared to the PSG (PSG-ORDI) using intraclass correlation coefficient and Bland-Altman analysis. Receiver operating characteristic curves (ROC) were constructed to optimise the diagnostic performance of the MM monitor at different PSG-ORDI thresholds (5, 15, and 30 events/hour). 31 patients were included in the analysis (58% men; mean (SD) age: 48 (15) years; BMI: 30.4 (7.6) kg/m The diagnosis of OSA, using MM with machine learning analysis, is comparable to manually scored in-home PSG. Therefore, this novel monitor could be a convenient diagnostic tool that can easily be used in the patients' own home. https://clinicaltrials.gov, identifier NCT04262557.

Sections du résumé

Background UNASSIGNED
The capacity to diagnose obstructive sleep apnoea (OSA) must be expanded to meet an estimated disease burden of nearly one billion people worldwide. Validated alternatives to the gold standard polysomnography (PSG) will improve access to testing and treatment. This study aimed to evaluate the diagnosis of OSA, using measurements of mandibular movement (MM) combined with automated machine learning analysis, compared to in-home PSG.
Methods UNASSIGNED
40 suspected OSA patients underwent single overnight in-home sleep testing with PSG (Nox A1, ResMed, Australia) and simultaneous MM monitoring (Sunrise, Sunrise SA, Belgium). PSG recordings were manually analysed by two expert sleep centres (Grenoble and London); MM analysis was automated. The Obstructive Respiratory Disturbance Index calculated from the MM monitoring (MM-ORDI) was compared to the PSG (PSG-ORDI) using intraclass correlation coefficient and Bland-Altman analysis. Receiver operating characteristic curves (ROC) were constructed to optimise the diagnostic performance of the MM monitor at different PSG-ORDI thresholds (5, 15, and 30 events/hour).
Results UNASSIGNED
31 patients were included in the analysis (58% men; mean (SD) age: 48 (15) years; BMI: 30.4 (7.6) kg/m
Conclusion UNASSIGNED
The diagnosis of OSA, using MM with machine learning analysis, is comparable to manually scored in-home PSG. Therefore, this novel monitor could be a convenient diagnostic tool that can easily be used in the patients' own home.
Clinical Trial Registration UNASSIGNED
https://clinicaltrials.gov, identifier NCT04262557.

Identifiants

pubmed: 35368281
doi: 10.3389/fnins.2022.726880
pmc: PMC8965001
doi:

Banques de données

ClinicalTrials.gov
['NCT04262557']

Types de publication

Journal Article

Langues

eng

Pagination

726880

Informations de copyright

Copyright © 2022 Kelly, Ben Messaoud, Joyeux-Faure, Terrail, Tamisier, Martinot, Le-Dong, Morrell and Pépin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Respirology. 2020 Jul;25(7):690-702
pubmed: 32436658
Br J Haematol. 2011 Oct;155(2):198-208
pubmed: 21848891
Sleep Med Rev. 2014 Aug;18(4):341-7
pubmed: 24388970
Am J Respir Crit Care Med. 2020 Aug 1;202(3):309-310
pubmed: 32510968
JAMA Cardiol. 2018 Jun 1;3(6):532-540
pubmed: 29541763
J Clin Sleep Med. 2013 Jan 15;9(1):81-7
pubmed: 23319910
Lancet Respir Med. 2019 Aug;7(8):687-698
pubmed: 31300334
Sleep Med Rev. 2018 Oct;41:149-160
pubmed: 30149930
Thorax. 2020 Dec;75(12):1095-1102
pubmed: 32792405
Lancet Respir Med. 2019 Aug;7(8):645-647
pubmed: 31300335
J Clin Sleep Med. 2015 Apr 15;11(5):567-74
pubmed: 25766710
J Clin Sleep Med. 2007 Dec 15;3(7):737-47
pubmed: 18198809
Eur Respir J. 2018 Sep 16;52(3):
pubmed: 29853491
IEEE Trans Biomed Eng. 2008 Jan;55(1):87-95
pubmed: 18232350
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32366489
Respir Physiol Neurobiol. 2020 Aug;279:103447
pubmed: 32416331
J Clin Sleep Med. 2017 May 15;13(5):665-666
pubmed: 28416048
JAMA Netw Open. 2020 Jan 3;3(1):e1919657
pubmed: 31968116
Sleep Breath. 2012 Jun;16(2):535-42
pubmed: 21660653
Sleep. 2013 Apr 01;36(4):591-6
pubmed: 23565005
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
Respirology. 2017 Apr;22(3):567-574
pubmed: 28225162
Chest. 2021 Mar;159(3):1222-1231
pubmed: 32980370
Syst Rev. 2021 Apr 9;10(1):104
pubmed: 33836806
J Clin Sleep Med. 2017 Apr 15;13(4):551-555
pubmed: 28095966
J Sleep Res. 2014 Dec;23(6):709-716
pubmed: 25078069
Chest. 2017 Nov;152(5):1070-1086
pubmed: 28527878
IEEE Trans Biomed Eng. 2009 Feb;56(2):303-9
pubmed: 19342328
Lancet Respir Med. 2020 Apr;8(4):349-358
pubmed: 31806413
J Sleep Res. 2015 Dec;24(6):730-8
pubmed: 26511017
World J Otorhinolaryngol Head Neck Surg. 2015 Sep 08;1(1):17-27
pubmed: 29204536
Chest. 2014 Nov;146(5):1387-1394
pubmed: 25367475
Eur Respir J. 2021 Mar 4;57(3):
pubmed: 33214202
J Sleep Res. 2013 Feb;22(1):96-103
pubmed: 22835145
J Clin Sleep Med. 2016 Jun 15;12(6):885-94
pubmed: 27070243
Nat Rev Dis Primers. 2015 Jun 25;1:15015
pubmed: 27188535
Sleep. 2014 Dec 01;37(12):1953-61
pubmed: 25325484
Sleep Med Rev. 2019 Dec;48:101204
pubmed: 31491655
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1181-1190
pubmed: 28636405
Front Neurol. 2017 Jul 21;8:353
pubmed: 28785240
Health Technol Assess. 2009 Jan;13(4):iii-iv, xi-xiv, 1-119, 143-274
pubmed: 19103134

Auteurs

Julia L Kelly (JL)

National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital, London, United Kingdom.

Raoua Ben Messaoud (R)

HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France.

Marie Joyeux-Faure (M)

HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France.
EFCR Laboratory, Thorax and Vessels division, Grenoble Alpes University Hospital, Grenoble, France.

Robin Terrail (R)

HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France.
EFCR Laboratory, Thorax and Vessels division, Grenoble Alpes University Hospital, Grenoble, France.

Renaud Tamisier (R)

HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France.
EFCR Laboratory, Thorax and Vessels division, Grenoble Alpes University Hospital, Grenoble, France.

Jean-Benoît Martinot (JB)

Sleep Laboratory, CHU Université catholique de Louvain (UCL) Namur Site Sainte-Elisabeth, Namur, Belgium.
Institute of Experimental and Clinical Research, UCL Bruxelles Woluwe, Brussels, Belgium.

Nhat-Nam Le-Dong (NN)

Sunrise, Namur, Belgium.

Mary J Morrell (MJ)

National Heart and Lung Institute, Imperial College London, Royal Brompton Hospital, London, United Kingdom.

Jean-Louis Pépin (JL)

HP2 Laboratory, Inserm U1300, Grenoble Alpes University, Grenoble, France.
EFCR Laboratory, Thorax and Vessels division, Grenoble Alpes University Hospital, Grenoble, France.

Classifications MeSH